Neobone® safety and performance in dental bone grafting
Official title: Evaluation of the Safety and Performance of the Neobone®: A Prospective Observational Study in Dental Area
Run by Bioceramed · NCT07179497 · Data updated 2026-11-12
This project will collect real-world data to see if Neobone® is safe and helps bone heal in adults having reconstructive dental procedures.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Bioceramed Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 1 site (Lisbon) |
| Status | Recruiting |
| Started | October 6, 2025 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07179497 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (over 18) undergoing reconstructive dental or maxillofacial surgery where the surgeon plans to use Neobone® and who can give informed consent are the intended participants.
✕Probably not a fit
Patients who require structural load-bearing support, have active local or systemic infections, metabolic bone disorders, unstable implantation sites, or known hypersensitivity to the implant materials are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Neobone® is a synthetic, resorbable biphasic calcium phosphate (hydroxyapatite and beta‑tricalcium phosphate) bone substitute intended for use in dental and maxillofacial grafting. This prospective observational study will gather clinical and safety data from adults who receive Neobone® during reconstructive dental surgery at the participating center. Collected information will include handling, wound healing, radiographic and clinical signs of bone integration, and any adverse events during follow-up. The results are intended to provide clinical evidence to support the device's performance and safety profile.
Why it matters
Potential benefit: If successful, Neobone® could provide a resorbable synthetic graft that supports bone regeneration and may reduce the need to harvest a patient’s own bone.
How similar studies have gone: Other clinical reports of biphasic hydroxyapatite/β‑TCP bone substitutes have shown positive bone integration in dental augmentation, but long-term device-specific evidence for Neobone® remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult males or females (age \> 18 years old); * Patients who are able to sign an informed consent form (for data collection); * Patients undergoing reconstructive dental surgery and indicated for the use of Neobone®; Exclusion Criteria: * Patients who are unable to understand consent and the objectives of the study; * Signs of local or systemic acute/ active or chronic infections; * Metabolic affections; * Severe degenerative diseases, conditions in which general bone grafting is not advisable; * Implementation sites that allow product migration; * Conditions which require structural support in the skeletal system; * Conditions where the implantation site is unstable and not rigidly fixated; * Sensibility to the implantable materials; * Known hypersensitivity to the implant material.
Where it's running
-
Egas Moniz School of Health and Science Caparica
Lisbon, Portugal Recruiting
Study contacts
- Principal investigator: João Botelho — Egas Moniz School of Health and Science Caparica
- Study coordinator: Alexandre Barros
- Email: info@bioceramed.com
- Phone: 253 573 460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced hydrogel xenograft for open maxillary sinus augmentation
This study tests a hydrogel-enhanced xenograft material to lift the sinus floor during open augmentation and sees if it improves bone formation and tissue response compared with doing the augmentation without graft material.
-
Neocement® Inject P for dental bone augmentation and regeneration.
This study will try Neocement® Inject P, an injectable calcium‑phosphate bone substitute, in adults having reconstructive dental or maxillofacial surgery to see if it is safe and helps bone heal.
-
Bone grafting at implant removal to help success of putting a new implant in the same spot
This study tests whether doing bone grafting at the same time as removing a failed dental implant helps people who plan to get a new implant in the same location.
-
Rebuilding upper jaw ridge using retromolar bone blocks with or without a collagen membrane
This will test whether putting a collagen membrane over an onlay bone block and particulate bone in the upper jaw helps people who need ridge rebuilding get more bone.
-
One-stage ridge splitting in the back lower jaw using two techniques
This compares two surgical methods—piezo surgery versus conventional bone-disc cuts—to widen the narrow back lower jaw so dental implants can be placed in adults with limited ridge width.
-
One-stage ridge splitting in the upper jaw using piezo surgery or a bone-disc technique
We will try two ridge-splitting techniques—piezo surgery and bone discs—to widen narrow upper-jaw bone in adults needing a single-tooth implant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.